Stimulation of DNA Glycosylase Activities by XPC Protein Complex: Roles of Protein-Protein Interactions by Shimizu, Yuichiro et al.
SAGE-Hindawi Access to Research
Journal of Nucleic Acids
Volume 2010, Article ID 805698, 12 pages
doi:10.4061/2010/805698
Research Article
Stimulation of DNA GlycosylaseActivities by XPC Protein
Complex:Rolesof Protein-Protein Interactions
YuichiroShimizu,1,2 YasuhiroUchimura,3 Naoshi Dohmae,4 HisatoSaitoh,3
FumioHanaoka,1,2 andKaoru Sugasawa1,5
1Cellular Physiology Laboratory, RIKEN Discovery Research Institute, Wako, Saitama 351-0198, Japan
2Graduate School of Frontier Biosciences, Osaka University, Suita, Osaka 565-0871, Japan
3Department of Biological Sciences, Graduate School of Science and Technology, Kumamoto University, Kumamoto 860-8555, Japan
4Biomolecular Characterization Team, RIKEN Discovery Research Institute, Wako, Saitama 351-0198, Japan
5Biosignal Research Center, Organization of Advanced Science and Technology, Kobe University, Kobe, Hyogo 657-8501, Japan
Correspondence should be addressed to Kaoru Sugasawa, ksugasawa@garnet.kobe-u.ac.jp
Received 30 April 2010; Accepted 9 June 2010
Academic Editor: Ashis Basu
Copyright © 2010 Yuichiro Shimizu et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
We showed that XPC complex, which is a DNA damage detector for nucleotide excision repair, stimulates activity of thymine DNA
glycosylase (TDG) that initiates base excision repair. XPC appeared to facilitate the enzymatic turnover of TDG by promoting
displacement from its own product abasic site, although the precise mechanism underlying this stimulation has not been clariﬁed.
Here we show that XPC has only marginal eﬀects on the activity of E. coli TDG homolog (EcMUG), which remains bound to
the abasic site like human TDG but does not signiﬁcantly interacts with XPC. On the contrary, XPC signiﬁcantly stimulates the
activities of sumoylated TDG and SMUG1, both of which exhibit quite diﬀerent enzymatic kinetics from unmodiﬁed TDG but
interactwithXPC.Theseresultspointtoimportanceofphysical interactionsforstimulationofDNAglycosylases byXPCandhave
implications in the molecular mechanisms underlying mutagenesis and carcinogenesis in XP-C patients.
1.Introduction
DNA,whichcarries thegenetic information, is liabletoalter-
ations by various agents of endogenous and environmental
origin. In order to prevent the deleterious eﬀects yielded
by such DNA lesions and to maintain the integrity of the
genome and cellular functions, cells are equipped with sev-
eral DNA repair systems, such as base excision repair (BER),
nucleotide excision repair (NER), and mismatch repair (for
review, see [1]). BER is one of the most versatile repair
pathways that can deal with base lesions resulting mainly
from alkylation, oxidation, deamination, and replication
errors. This pathway is initiated by damage-speciﬁc DNA
glycosylases that release the altered or inappropriate bases
by cleavage of the N-glycosylic bond from the phosphate-
sugar backbone, thereby resulting in production of the
apurinic/apyrimidinic (AP) sites (reviewed in [2, 3]). The
phosphodiester bond 5  to the AP site is then nicked by
AP endonucleases. A class of DNA glycosylases, designated
bifunctional DNA glycosylases, possess additional AP lyase
activity that further cleaves the phosphodiester bond 3  to
the AP site generated by its own glycosylase activity. When
BER is initiated by such bifunctional DNA glycosylases, AP
endonuclease removes 3 -unsaturated aldehyde left behind
by the AP lyase activity. As a consequence of either pathways,
3 -OH end is generated which is suitable for the following
DNA repair synthesis.
Unlike BER that mainly repairs base lesions, NER deals
with a wide variety of helix-distorting lesions, including
ultraviolet (UV) light-induced pyrimidine photodimers as
well as intrastrand crosslinks and bulky adducts induced by
numerous chemical compounds. Xeroderma pigmentosum
(XP) is one of the autosomal recessive disorders that are
associated with defective NER and clinically characterized
by severe photosensitivity against UV exposure and a
high risk of skin cancer. To date, seven NER-deﬁcient XP2 Journal of Nucleic Acids
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Figure 1: DNA substrates used in this study.
genetic complementation groups have been identiﬁed (XP-
A through -G), for each of which the responsible gene
has been cloned [4]. Unlike most of the other XP groups,
XP-C patients show defects only in one of the two NER
subpathways, that is, global genome NER that covers the
entire genome. The other subpathway is referred to as
transcription-coupled NER, which repairs transcription-
blocking lesions on the transcribed strand of active genes.
The XPC protein, the responsible gene product for the XP
group C, plays an essential role in DNA damage recognition
and the following initiation of global genome NER [5–
7]. It forms in vivo a stable heterotrimeric complex with
either RAD23A or RAD23B, one of the two mammalian
homologues of Saccharomyces cerevisiae Rad23p, and centrin
2, which is known also as a component of the centrosome
[8–10]. RAD23 stabilizes the XPC protein in vivo [11, 12],
andtheXPC-RAD23heterodimerissuﬃcienttoreconstitute
the cell-free NER reaction [13, 14], whereas centrin 2
appears to potentiate the damage-speciﬁc DNA binding
activityoftheXPCcomplex[15].Biochemicalandstructural
analysesrevealedthatthiscomplexrecognizesaspeciﬁcDNA
secondary structure containing a junction between double-
stranded DNA and a single-stranded 3 -overhang [16–18].
After the DNA binding by XPC, ATPase/helicase activities of
TFIIH (exerted by the XPB and XPD subunits) open DNA
duplexanddemarcatedamage,probablywiththeaidofXPG,
XPA, and replication protein A (RPA). The damaged strand
is then cleaved in both sides of the lesion by two structure-
speciﬁc NER endonucleases, ERCC1-XPF and XPG, and the
resulting gap is reﬁlled with the DNA repair synthesis [19].
We have previously shown that XPC interacts directly
with one of the DNA glycosylases, thymine DNA glycosylase
(TDG) [20]. TDG removes thymine or uracil residues from
G/T or G/U mismatches, which are mainly derived from
hydrolytic deamination of 5-methylcytosines or cytosines,
respectively (for review, see [21]). TDG is unique in that
it cannot dissociate from the substrate DNA by itself
after accomplishing its enzymatic activity [22, 23]. Crystal
structure of the E. coli homolog of TDG, the mismatch-
speciﬁc uracil DNA glycosylase (EcMUG), demonstrated
that the inability to turnover is due to its tight interaction
with the guanine opposite the AP site [24, 25]. Extensive
biochemical analyses have suggested that this feature may
be applicable also to the human TDG [22, 23, 26]. Since
continuous attachment of TDG to AP sites must interfere
with the following BER process, it has been conceivable that
there should be certain factors that promote dissociation
of TDG from the processed DNA. One candidate for such
factors relieving TDG of the product inhibition is AP
endonuclease 1 (APE1), which acts in the BER pathway
immediatelyaftertheDNAglycosylases[22,27–29].Another
factor would be sumoylation of TDG, which occurs at a
single speciﬁc site (Lys330 in human TDG) [30]. The X-
ray crystal structure of sumoylated TDG revealed that this
modiﬁcation induces a signiﬁcant conformational change in
the C-terminal domain of TDG, which seems to sterically
prevent its interaction with DNA [31]. Thus, it has been
proposed that the sumoylation following base excision may
promote the enzymatic turnover of TDG [32], although
precise timing and regulation of the modiﬁcation in vivo
still remain to be elucidated. In addition, we have previously
shown that XPC-RAD23B forms a ternary complex with
TDG bound to the substrate DNA and promote dissociation
of TDG from the AP site [20]. Like TDG and APE1, XPC can
recognizeandbindtoAPsites,althoughtheobservedaﬃnity
is relatively low if opposite base is guanine [20]. Therefore,
two notions have been conceivable concerning molecular
mechanisms underlying the stimulation of TDG turnover
by XPC: direct physical interaction and competition for
the AP site. More recently, it has been reported that XPC
interacts with and stimulates the activity of OGG1, a major
DNA glycosylase that removes various oxidative base lesions
including 8-oxoguanine [33]. Here we further investigate
possible involvement of the XPC protein complex in BER
by using various DNA glycosylases as well as a sumoylated
form of TDG, which gives further insights to the molecular
mechanisms for the TDG stimulation.
2.MaterialsandMethods
2.1. Puriﬁcation of Recombinant Proteins. Puriﬁcation
of recombinant human XPC and His-tagged RAD23B
(RAD23B-His) was carried out [34, 35], and the XPC-
RAD23B-His heterodimer was reconstituted in vitro as
described previously [17]. His-TDG, GST-TDG, GST, and
His-SMUG1 were also puriﬁed as described elsewhere
[20, 36].
EcMUG and UNG2, both fused to the N-terminal His-
tag, were expressed in E. coli strain BL21 (DE3) using the
pET-28a vector (Novagen). Expression of His-EcMUG was
induced with 1mM isopropyl-β-d-thiogalactopyranoside
(IPTG) at 37
◦C for 3 hours. The bacterial cell pellets were
sonicated in buﬀer A [25mM sodium phosphate (pH 7.5),
1mM EDTA, 25mM NaCl, 0.01% Nonidet P-40, 1mM
dithiothreitol (DTT), 0.25mM phenylmethylsulfonyl ﬂuo-
ride (PMSF), protease inhibitor cocktail (Complete; Roche
Diagnostics)] and centrifuged for 30 minutes at 100,000g.Journal of Nucleic Acids 3
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Figure 2: XPC stimulates the activity of TDG that cleaves uracil
from G/U mismatches. The activity of TDG was measured by using
1.6nM of 60-bp DNA containing a single G/U mismatch as a
substrate. The reaction was done at 30
◦C for the indicated time
with 0.42nM His-TDG in the presence of various concentrations of
XPC-RAD23B. The DNA samples were then puriﬁed and subjected
to alkali-treatment to cleave the resulting AP sites and separated
with denaturing PAGE. The ratio of the cleaved product was
calculated and plotted as a graph. The mean values and standard
errors were calculated from at least two independent experiments.
Thesupernatantwasloadedontoaphosphocellulosecolumn
(P-11; Whatman) equilibrated with buﬀer B [20mM sodium
phosphate (pH 7.5), 10% glycerol, 0.01% Triton X-100,
0.25mM PMSF] containing 0.1M NaCl. After the resin was
washed thoroughly with the same buﬀer, bound proteins
were eluted stepwise with buﬀer B containing 0.2 and 1M
NaCl. Proteins recovered in the 1M NaCl fraction were then
applied to a column packed with TALON resin (Clontech)
equilibrated with buﬀer C [20mM Tris-HCl (pH 7.5),
10% glycerol, 0.1M NaCl, 0.01% Triton X-100, 0.25mM
PMSF] containing 5mM imidazole. The column was then
washedextensivelywiththesamebuﬀer,followedbystepwise
elution of the bound proteins with buﬀer C containing 20,
100, and 250mM imidazole. Finally, the 100mM imidazole
fraction containing His-EcMUG was dialyzed against buﬀer
D [20mM sodium phosphate (pH 7.5), 1mM EDTA, 10%
glycerol, 0.01% Triton X-100, 1mM DTT, 0.25mM PMSF]
containing 0.2M NaCl.
Expression of His-UNG2 was induced with 1mM IPTG
at 30
◦C for 3 hours. The bacterial cell extract was prepared
as described above and loaded onto a HiLoad 16/10 SP
Sepharose HP column (GE Healthcare Biosciences) equili-
brated with buﬀer B containing 0.1M NaCl. After washing
the resin with the same buﬀer, bound proteins were eluted
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Figure 3: XPC physically interacts with SUMO-1-conjugated TDG,
but not with EcMUG. Glutathione-Sepharose beads (20μl) were
incubated in 100μl of the binding mixture containing 10nM of
GST(negativecontrol),GST-TDG(positivecontrol),GST-EcMUG,
or SUMO-1-GST-TDG in the presence of the same concentration
of XPC-RAD23B. After extensive washing, bound proteins were
eluted with buﬀer containing 10mM glutathione. One-fourth of
each eluate was mixed with whole cell extract from XP4PASV cells
whichdonotexpressXPCandsubjectedto8%SDS-PAGEfollowed
by immunoblotting with anti-XPC antibody (upper panel). The
same samples were also subjected to 12% SDS-PAGE followed by
immunoblotting with anti-GST antibody (lower panel).
stepwise with buﬀer B containing 0.5 and 1M NaCl. His-
UNG2 recovered in the 0.5M NaCl fraction was further
puriﬁed with TALON resin, exactly as described above
for His-EcMUG. The 250mM imidazole fraction was then
loaded onto a Mono S PC 1.6/5 column equilibrated with
buﬀer D containing 0.1M NaCl. The column was developed
with a linear gradient of 0.1–0.7M NaCl in buﬀer D and His-
UNG2 was eluted around 0.4M NaCl. Finally, the sample
was subjected to gel ﬁltration chromatography using a
Superdex 75 PC 3.2/30 column (GE Healthcare Biosciences)
equilibrated with buﬀer D containing 0.2M NaCl.
Sumoylation of His-TDG was conducted in E. coli strain
BL21 (DE3) as described [37]. After induction of protein
expression with 1mM IPTG at 30
◦Cf o r3h o u r s ,b a c t e r i a l
cell extract was prepared and fractionated on SP Sepharose
and TALON columns exactly as described above for His-
UNG2. The 250mM imidazole fraction from the TALON
column containing SUMO-1-His-TDG was subsequently
loaded onto a Mono Q HR 5/5 column (GE Healthcare
Biosciences) equilibrated with buﬀer E [20mM Tris-HCl
(pH 7.5), 1mM EDTA, 10% glycerol, 0.01% Triton X-100,
1mM DTT, 0.25mM PMSF] containing 0.1M NaCl. The
column was developed with a linear gradient of 0.1–0.5M
NaCl in buﬀer E and SUMO-1-His-TDG was eluted around4 Journal of Nucleic Acids
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Figure 4: The eﬀect of XPC on the activity of EcMUG that cleaves
uracil from G/U mismatches. The activity of EcMUG was measured
by using 1.6nM of 60-bp DNA containing a single G/U mismatch
as a substrate. The reaction was done at 30
◦C for the speciﬁed time
with 0.8nM His-EcMUG and indicated concentrations of XPC-
RAD23B. The DNA samples were then puriﬁed and subjected to
alkali-treatment to cleave the resulting AP sites and separated with
denaturing PAGE. The ratio of the cleaved product was calculated
and plotted as a graph. The mean values and standard errors were
calculated from at least two independent experiments.
0.2M NaCl. Finally, proteins were loaded onto a Mono S PC
1.6/5 column equilibrated with buﬀer D containing 0.1M
NaCl and then eluted with a linear gradient of 0.1–0.5M
NaCl in buﬀer D. SUMO-1-His-TDG was collected from the
f r a c t i o n sa r o u n d0 . 2MN a C l .
GST-fusion proteins were expressed in E. coli strain BL21
(DE3) using the expression vector pGEX4T3 and puriﬁed
through two successive chromatography procedures using
a GSTrap column (GE Healthcare Biosciences) and then a
Mono S PC 1.6/5 column.
Flag-tagged MBD4 (Flag-MBD4) was expressed in insect
cells using the Bac-to-Bac baculovirus expression system
(Invitrogen). High Five cells were infected with the recom-
binant baculovirus, and proteins were extracted from the
cells with buﬀer F [25mM Tris-HCl (pH 8.0), 1mM EDTA,
0.3M NaCl, 10% glycerol, 1% Nonidet P-40, 1mM DTT,
0.25mM PMSF, protease inhibitor cocktail (Complete)] and
dialyzed against buﬀer D containing 0.1M NaCl. Samples
were then loaded onto a HiLoad 16/10 SP Sepharose HP
column(GEHealthcareBiosciences)equilibratedwithbuﬀer
D containing 0.1M NaCl. After washing the column with the
same buﬀer, bound proteins were eluted stepwise with buﬀer
D containing 0.5 and 1M NaCl. The 0.5M NaCl fraction
was subsequently loaded to an anti-Flag M2-agarose column
(Sigma-Aldrich) and eluted with buﬀe rDp l u s1 MN a C l
and 0.1mg/ml 3x Flag-peptide (Sigma-Aldrich). The eluate
was adjusted at 0.3M NaCl by dilution with buﬀer B and
then loaded to a HiTrap heparin HP column (GE Healthcare
Biosciences) equilibrated with buﬀer D containing 0.3M
NaCl. Bound proteins were eluted stepwise with buﬀer D
containing 0.5 and 1M NaCl, and Flag-MBD4 appeared in
the 1M NaCl fraction. Finally, the fraction was diluted by
buﬀer D in order to decrease the NaCl concentration to
0.3M again and subjected to a Mono S PC 1.6/5 column
equilibrated with buﬀer D containing 0.3M NaCl. The
elution of the bound protein was conducted with a linear
gradient of 0.3–1M NaCl in buﬀer D, where Flag-MBD4 was
collected from the fractions around 0.5M NaCl.
2.2. Nicking Assay. The enzymatic activities of DNA glyco-
sylases in the presence or absence of XPC-RAD23B were
measured as described previously [20]. Substrates used (G/T,
G/U, and ss-U) are shown in Figure 1.
2.3. GST Pull-Down Assay. Glutathione-Sepharose 4 fast
ﬂow (GE Healthcare Biosciences: 20μl) was mixed with
recombinant proteins as indicated in 100μl of the binding
buﬀer 20mM sodium phosphate (pH 7.4), 1mM EDTA,
150mM NaCl, 1mM DTT, 5% glycerol, 0.01% Triton X-100,
100μg/ml bovine serum albumin. After incubation on ice
for 1 hour with occasional agitation, the beads were washed
eight times with 500μl of the binding buﬀer and the proteins
retained on the beads were eluted using 20μl of the binding
buﬀercontaining10mMglutathione.SincepuriﬁedXPChas
a tendency to aggregate when boiled in the presence of SDS,
each eluate was mixed before denaturation with the whole
cell extract (0.4μg protein) from XP4PASV cells that do not
express endogenous XPC [20]. An aliquote of each eluate
mixed with XP4PASV cell extract was subjected to 8% SDS-
PAGE and analyzed by immunoblotting using polyclonal
anti-XPC or anti-GST antibodies.
2.4. Antibodies. The polyclonal antibodies against XPC and
T D Gw e r er a i s e da sd e s c r i b e dp r e v i o u s l y[ 20, 35]. The
polyclonal anti-GST (GE Healthcare Biosciences) and anti-
SUMO-1 (Santa Cruz Biotechnology) antibodies were pur-
chased.
3. Results
3.1. XPC Stimulates the Repair of G/U Mismatches Initiated
by TDG. We ﬁrst examined whether XPC can stimulate
the enzymatic activity of TDG that removes uracils from
the G/U mismatches by the conventional DNA glycosylase
assay involving the substrate shown in Figure 1(a).W eh a v e
previously shown by using the DNA substrate containing
a single G/T mismatch that XPC-RAD23B stimulates the
activity of TDG by promoting dissociation of the enzyme
from the AP site [20]. Although TDG has been shown
to exhibit signiﬁcantly higher activity with G/U than G/T
mismatches, the severe product inhibition has been also
observed with the G/U substrate [23]. In this point ofJournal of Nucleic Acids 5
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Figure 5: The eﬀect of XPC on the activity of SUMO-1-modiﬁed TDG that cleaves uracil from G/U mismatches. (a) Silver staining of the
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and subjected to alkali-treatment to cleave the resulting AP sites and separated with denaturing PAGE. The ratio of the cleaved product was
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view, the eﬀect of XPC on TDG may be similar regardless
of which substrate is used, because the AP site opposite
guanine is in any way produced as a result of the enzymatic
action. Compared with the reaction kinetics of TDG alone,
addition of XPC-RAD23B stimulated the activity of TDG on
G/U mismatches up to 5-fold in a dose-dependent manner
(Figure 2), exactly as expected.
3.2. XPC Has Only a Marginal Eﬀect on the Activity of E.
coli Homolog of TDG. In order to test the signiﬁcance of
protein-protein interaction between XPC and TDG for the
stimulation, we puriﬁed an E. coli homolog of TDG, the
mismatch-speciﬁc uracil-DNA glycosylase (EcMUG) [38].
UnlikeTDG,whichisinvolved incorrectionofboth G/Tand
G/U mismatches, EcMUG is primarily G/U-speciﬁc, with
very low activity toward G/T mismatches [24]. However,
EcMUG resembles human TDG in that, after cleavage of
the particular bases, it remains tightly bound to the AP
site generated after exhibiting the glycosylase activity [22–
25]. We ﬁrst tested the presence or absence of physical
interaction between XPC and EcMUG fused to glutathione
S-transferase (GST-EcMUG). Ten nanomolar each of GST-
EcMUG, GST-TDG as a positive control, or GST alone as
a negative control was mixed with the equal concentration
of XPC-RAD23B, and proteins were pulled down with
glutathione-Sepharose beads. Immunoblot analyses revealed
that a signiﬁcant amount of XPC was bound to GST-TDG
whereas only little amount of XPC was bound to GST alone
as expected (Figure 3, compare lanes 1 and 2; see also [20]).
It should be noted that the amount of GST-TDG recovered
in the bound fraction was only ∼20% of GST. Meanwhile,
the binding between XPC and EcMUG was as much as the
background level (Figure 3, compare lanes 1 to 3), indicating
that XPC-RAD23B does not interact with EcMUG in vitro
under the conditions tested.
We next added XPC into the nicking assay using the G/U
substrate in order to see whether it inﬂuences the activity
of EcMUG. Although signiﬁcant physical interaction could
notbe detected(Figure 3), it waspossible that XPC-RAD23B
may still stimulate the activity of EcMUG by displacing the
glycosylase from the AP site, since XPC itself also seems to
have a binding aﬃnity toward the AP site [20]. As shown in
Figure 4,however ,XPChardlyaﬀectedtheenzymaticactivity
of EcMUG; while 0.8nM EcMUG processed about 6% of the
substrate DNA (1.6nM) within 120 minutes, ∼9% of the
uracil was removed from the G/U mismatched-DNA in the
presence of 4nM XPC-RAD23B. Although there might be
thus a very weak stimulation, the eﬀect of XPC on EcMUG
activity was much less pronounced than that on TDG.
3.3. XPC Stimulates the Activity of Sumoylated TDG. A
covalent modiﬁcation of TDG by SUMO-1 was shown to
dramatically aﬀect its DNA binding properties [30, 32].
Consequently, TDG appears to lose its activity on G/T
mismatches, whereas the excision of uracils from G/U sub-
strates is even enhanced upon sumoylation. The stimulation
of the uracil cleavage seemed to be due to relief of TDG
from the product inhibition via SUMO-1 conjugation [30].
Given that the sumoylated TDG may not be bound to
the AP site so stably, it was of our great interest to know
whether XPC can interact with and stimulate the activity
of the modiﬁed enzyme. To test this idea, we prepared
SUMO-1-conjugated TDG by expressing E1 (Aos1-Uba2),
E2 (Ubc9), SUMO-1, and TDG (His- or GST-tagged) in
E. coli simultaneously, which enables eﬃcient sumoylation
of TDG within bacteria [37]. The sumoylated His-TDG
(Figure 5(a)) and GST-TDG (data not shown) were puriﬁed
to near homogeneity. We conﬁrmed that the puriﬁed protein
speciﬁcally reacts with both anti-TDG and anti-SUMO-1
antibodies (Figure 5(b)). Analysis of the protease-digested
fragments with mass spectrometry and peptide sequencing
further demonstrated that SUMO-1 is conjugated exactly to
the predicted site (Lys330 of TDG; data not shown).
At ﬁrst, we tested a protein-protein interaction between
XPC and the sumoylated TDG by GST pull-down assay.
As shown in Figure 3, a signiﬁcant amount of XPC was
coprecipitated with SUMO-1-GST-TDG if compared to GST
alone, and approximately 2-fold more XPC appeared to
bind to SUMO-1-GST-TDG than to nonmodiﬁed GST-
TDG. This indicates that XPC can bind to TDG regardless
of the presence or absence of modiﬁcation by SUMO-1.
We then examined whether XPC can aﬀect the activity
of SUMO-1-TDG. As reported by Hardeland et al. [30],
the puriﬁed recombinant SUMO-1-TDG had only marginal
activity for G/T mismatches (data not shown). On the
other hand, SUMO-1-TDG showed nearly linear kinetics
of uracil removal from G/U mismatches up to 120-minute
incubation, suggesting that the product inhibition was much
less pronounced as described previously (Figure 5(c);[ 30]).
Interestingly, this activity of SUMO-1-TDG was further
stimulated by the addition of XPC in a dose-dependent
manner (Figure 5(c)). Incubation of 4nM XPC-RAD23B
resulted in ∼5-fold processing of the G/U mismatch in 120
minutes, and this ratio was comparable to the stimulation of
nonmodiﬁed TDG cleaving the same substrate (Figure 5(c)).
Thus, these results demonstrate that XPC can upregulate the
activity of not only nonmodiﬁed TDG but also SUMO-1-
modiﬁed TDG in vitro.
3.4. Eﬀects of XPC on Other DNA Glycosylases. Since it
has been reported that XPC stimulates OGG1 in addi-
tion to TDG, we next investigated the eﬀect of XPC on
various DNA glycosylases, especially the monofunctional
DNA glycosylases that are involved in G/T and/or G/U
mismatch repair, including UNG2, MBD4 (also referred to
as MED1), and SMUG1. UNG2 and SMUG1 mainly remove
uracils not only from double-stranded DNA but also from
single-stranded DNA, whereas MBD4 as well as TDG is
more or less specialized toward correction of G/T and G/U
mismatches particularly in the CpG context. As shown in
Figure 6, XPC showed no obvious eﬀect on the activity of
UNG2 against G/U mismatch (Figure 6(a)), that of MBD4
againstG/Tmismatch(Figure 6(b)),orthatofMBD4against
G/U mismatch (data not shown). Although the activities
of both UNG2 and MBD4 were somewhat reduced in
the presence of XPC, this may be due to the nonspeciﬁcJournal of Nucleic Acids 7
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Figure 6: The eﬀect of XPC on the activity of other DNA glycosylases involved in G/T and/or G/U mismatch repair. The activity of UNG2
(a), MBD4 (b), or SMUG1 ((c) and (d)) was measured in the presence of various amounts of XPC-RAD23B. In each reaction, 1.6nM of
60-bp DNA containing a single G/U mismatch ((a) and (c)), G/T mismatch (b), or single stranded 30-mer oligonucleotide containing a
single uracil residue (d) was used as the substrate. The reaction was done at 30
◦C for the time indicated with speciﬁed concentration of
puriﬁed recombinant proteins as shown. The DNA samples were then puriﬁed and subjected to alkali-treatment to cleave the resulting AP
sites and separated with denaturing PAGE. The ratio of the cleaved product was calculated and plotted as a graph. The mean values and
standard errors were calculated from at least two independent experiments.8 Journal of Nucleic Acids
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Figure 7: XPC interacts physically with SMUG1 in vitro.
Glutathione-Sepharose beads (20μl) were incubated in 100μlo f
the binding mixture with 10nM of either GST or GST-TDG in
the presence of the same concentration of XPC-RAD23B. After
extensive washing, bound proteins were eluted with buﬀer con-
taining 10mM glutathione. One-fourth of each eluate was mixed
with whole cell extract from XP4PASV cells which do not express
XPC and subjected to 8% SDS-PAGE followed by immunoblotting
with anti-XPC antibody (upper panel). The same samples were
alsosubjectedto12%SDS-PAGEfollowedbyimmunoblottingwith
anti-GST antibody (lower panel).
binding of XPC to DNA. On the contrary, XPC showed a
striking stimulation on the activity of SMUG1 against G/U
mismatch in a dose-dependent manner (Figure 6(c)). In the
absence of XPC, 2.5pM SMUG1 processed about 5% of
1.6nM G/U-mismatched DNA in 120 minutes under the
conditions tested. Meanwhile, the presence of 2nM XPC-
RAD23B boosted the SMUG1 activity up to 4-fold under the
equivalent conditions. This stimulation was also observed
when a single-stranded 30-mer oligonucleotide containing
a single uracil residue was used as a substrate (Figures 1
and 6(d)). While 62.4pM SMUG1 cleaved about 2% of
the substrate (1.6nM) in 120 minutes, addition of 1nM
XPC-RAD23B stimulated the cleavage up to 8% under the
same conditions. Although SMUG1 is known to remove
uracils more eﬃciently from single-stranded DNA than
from double-stranded DNA, our results showed the opposite
pattern. This might be due to the diﬀerence in length of the
substrate DNA between G/U-mismatched double-stranded
DNA (60bp) and single-stranded DNA (30mer) [39]. These
results suggest that XPC functionally interacts not only with
TDG but also with SMUG1.
3.5. XPC Physically Interacts with SMUG1. Since our results
indicate that XPC could stimulate the activity of SMUG1
in vitro, we tested the existence of the protein-protein
interaction between XPC and SMUG1 by using the GST-pull
down assay (Figure 7). Ten nanomolar each of GST or GST-
fused SMUG1 was incubated with an equimolar amount of
XPC-RAD23B,andthenboundtotheglutathione-Sepharose
beads. After eluting the bound protein with glutathione, the
presence of GST and GST-SMUG1 or XPC was visualized
by immunoblotting using anti-GST or anti-XPC antibody,
respectively. While equivalent molar amounts of GST and
GST-SMUG1 were observed within the eluates, only little
amount of XPC was bound to the control GST. On the
other hand, a signiﬁcant amount of XPC was pulled-
down with GST-SMUG1. Although this protein-protein
interaction seems to be relatively weak (only ∼0.4% of the
input was bound to XPC), these results indicate presence of
a direct interaction between XPC and SMUG1.
4. Discussion
4.1. Mechanistic Implications on the Enzymatic Turnover of
T D GP r o m o t e db yX P C .In this study, we have further
examined the molecular mechanisms of interaction between
XPC and TDG that facilitate the enzymatic turnover of
TDG. In our previous studies, XPC appeared to promote
dissociation of TDG from the AP site that is generated by
its own glycosylase activity on G/T mismatch [20]. At least
two possible mechanisms have been considered, which could
contribute to the displacement of TDG from the abasic
reaction product: (1) protein-protein interaction between
XPC and TDG weakens the binding aﬃnity of TDG to the
substrate DNA, and (2) XPC and TDG compete for the same
AP site, and thus TDG is pushed out. In order to examine
which factor is more critical for the enhanced enzymatic
turnover, EcMUG, an E. coli homolog of mammalian TDG,
was utilized as a model that can bind to the AP site as well
as TDG [24, 25] but cannot interact with XPC (Figure 3).
Our results indicate that the stimulation of EcMUG by
XPC is almost negligible when compared to human TDG
(Figure 4).Althoughtheremightbeveryweakstimulationof
EcMUG, which could be due to competitive displacement of
the enzyme from the AP site by XPC-RAD23B, these results
point to importance of the protein-protein interaction for
the stimulation of TDG by XPC. In agreement with this
idea, we show here that XPC also stimulates the activities
of sumoylated TDG and SMUG1, both of which interact
physically with XPC (Figures 3 and 7).
Ourpresentdataalsoindicatethatverystableassociation
of DNA glycosylase with the produced AP site is not a
prerequisite for stimulation by XPC. It has been reported
that modiﬁcation of TDG by SUMO alters its structure
in the C-terminal domain, which leads to the release of
TDG from the AP site and therefore induces accelerated
enzymatic turnover [30–32]. In fact, in contrast to the
immediately saturating reaction patterns of unmodiﬁed
TDG, the sumoylated enzyme exhibited a nearly linear
kinetics of uracil removal from G/U mismatches. Even under
these conditions, intriguingly, XPC has an ability to further
stimulate the activity of SUMO-1-TDG. It is possible that,Journal of Nucleic Acids 9
like the reported case for OGG1, XPC may stimulate loading
of certain DNA glycosylases to substrate DNA. Although
competition with XPC for the AP site may not be suﬃcient
by itself to displace the tightly bound DNA glycosylase, our
data do not exclude that the binding aﬃnity of XPC to the
AP site may still contribute to promotion of the enzymatic
turnover. Considering the fact that XPC and APE1 stimulate
the activity of TDG in an additive fashion [20] and that
APE1 also further stimulates the activity of SUMO-1-TDG
[30], XPC, sumoylation, and APE1 might be collaborating
to control the repair of G/T and G/U mismatches positively
in vivo. To understand the relationship between these three
factors in detail, in vivo regulation of the TDG sumoylation
should be clariﬁed in the future experiments. In addition, it
hasbeenshownthatXPCundergoesinvivoposttranslational
modiﬁcations, such as ubiquitylation [40, 41], sumoylation
[41], and phosphorylation [42, 43]. Although the observed
stimulation of DNA glycosylases seemed to occur in the
absence of these modiﬁcations, it is still possible that one
or more of these modiﬁcations may aﬀect interaction with
and/or stimulation of some DNA glycosylases.Future studies
would be necessary to address such intriguing possibility.
4.2. Possible Roles of Interactions between XPC and TDG/
SMUG1 in Prevention of Mutagenesis and Carcinogenesis.
Mammalian cells contain at least four nuclear DNA glyco-
sylases that can correct G/U and/or G/T mismatches, that
is, TDG, UNG2, MBD4, and SMUG1. Although precise
niche for each of these DNA glycosylases remains to be
clariﬁed, their biological roles have been suggested through
observations of in vivo behaviors and through interacting
partners. UNG2 seems to be specialized in counteracting
U:A base pairs formed by misincorporation of dUTP during
DNA replication. Among the uracil-DNA glycosylases, only
UNG2 speciﬁcally accumulates in the replication foci during
the S phase, thereby colocalizing with proliferating cell
nuclear antigen (PCNA) and RPA [44]. On the other hand,
SMUG1 was ﬁrst identiﬁed by in vitro expression cloning
[39] and also independently found to be a backup enzyme
for UNG2 [45, 46]. Unlike UNG2, SMUG1 may account
for the repair of replication-independent premutagenic G/U
mispairs resulting from cytosine deamination in vivo, since
it is expressed similarly in nonproliferating and proliferating
cells [45] and it does not colocalize with PCNA during
the S phase [47]. TDG and MBD4 apparently have very
similar substrate speciﬁcities: G/T and G/U mispairs that
are spontaneously generated by deamination of cytosines in
CpG dinucleotides. Besides its function in BER, TDG is also
known to interact with and regulate several transcription
factors [48–51]. MBD4 interacts with a mismatch repair
protein MLH1 [52], which may be involved in regulation
of some DNA damage response pathways [53]. Interestingly,
human UNG, TDG, and SMUG1 genes are closely located
within the long arm of chromosome 12, and these genes are
believedtobethederivativesfromanidenticalancestralgene
[54]. In fact, structural studies revealed that they contain
several common folds despite rather low (∼10%) amino acid
sequence homology [55, 56]. In these points of view, TDG
and SMUG1 might still possess the common surface that
might be the remnant of the ancestor to interact with XPC.
It has been reported that TDG is able to process certain
oxidative pyrimidine lesions, such as thymine glycol, 5-
hydroxyuracil,and5-hydroxymethyluracil,whenpairedwith
guanine [21]. In addition, SMUG1 was shown to be a
primary repair enzyme for a subset of oxidized uracil deriva-
tives such as 5-formyluracil, 5-hydroxymethyluracil, and 5-
hydroxyuracil in both single- and double-stranded DNA [57,
58]. Taken together with the recent report showing that XPC
stimulates the activity of OGG1 [33], these ﬁndings suggest
that XPC might be involved in repair of diverse oxidative
DNAlesions.Infact,lackofendogenousXPCseemstoresult
in ineﬃcient repair of spontaneous oxidative DNA damage.
Interestingly,whileasigniﬁcantamountofH2O2 isproduced
uponUVirradiationinmostofthecomplementationgroups
of the XP cells including XP-C compared to normal cells
[59], plasmid reactivation assays revealed that only XP-C
cells exhibited markedly reduced repair capacity for some
singlet oxygen-induced DNA lesions [60]. Furthermore,
extensive mutational analyses of the Trp53 of UVB-induced
skin tumors in Xpc−/− mice revealed a mutational hotspot
at a nondipyrimidinic CpG site in codon 122 [61, 62]. At
this site, C to T transition has been frequently detected
speciﬁcally in Xpc−/− mice (not in Xpa−/− or Csa−/− mice),
which is plausibly explained by reduced TDG activity in the
absence of functional XPC protein. However, the tandem
mutations AC > TT and AC > CT have been also found
at the same site, which cannot be attributed either to UV-
induceddipyrimidinic photolesionsortodeaminationofthe
cytosine alone. In addition, it has been reported that age-
dependent spontaneous mutations signiﬁcantly accumulate
in Xpc−/− mice even without UV exposure [63], and p53
gene mutations were identiﬁed in internal tumors of XP-
C patients [64]. Many of these mutations are less likely
to be the result of defects in correction of G/T and/or
G/U mismatches. It could be possible that impaired repair
of certain types of oxidative damage may be involved in
occurrence of these mutations.
5. Conclusions
Here we show that XPC stimulates activities of a certain
spectrum of DNA glycosylases, for which protein-protein
interactions seem to be important, rather than competition
for AP sites. In order to clarify the signiﬁcance of interaction
between XPC and TDG or SMUG1 in vivo, it should
be necessary to understand the precise physiological roles
of the diﬀerent thymine- and uracil-DNA glycosylases.
Further studies would reveal novel and important aspects in
understanding the mutagenesis and carcinogenesis in XP-C
patients.
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